section name header

Pronunciation

ep-i-NEF-rin

Classifications

Therapeutic Classification: antiasthmatics, bronchodilators, vasopressors

Pharmacologic Classification: adrenergics

Indications

IM:

High Alert


Local/Spinal

Unlabeled Use:

IV, Intracardiac, Intratracheal, Intraosseous (part of advanced cardiac life support [ACLS] and pediatric advanced life support [PALS] guidelines)

Action

  • Results in the accumulation of cyclic adenosine monophosphate (cAMP) at beta-adrenergic receptors.
  • Affects both beta1(cardiac)-adrenergic receptors and beta2(pulmonary)-adrenergic receptor sites.
  • Produces bronchodilation.
  • Also has alpha-adrenergic agonist properties, which result in vasoconstriction.
  • Inhibits the release of mediators of immediate hypersensitivity reactions from mast cells.
Therapeutic effects:
  • Bronchodilation.
  • Maintenance of heart rate and BP.
  • Localization/prolongation of local/spinal anesthetic.

Pharmacokinetics

Absorption: IV administration results in complete bioavailability; well absorbed following SUBQ administration; some absorption may occur following repeated inhalation of large doses.

Distribution: Does not cross the blood-brain barrier; crosses the placenta and enters breast milk.

Metabolism/Excretion: Action is rapidly terminated by metabolism and uptake by nerve endings.

Half-Life: Unknown.

Time/Action Profile

(bronchodilation)

ROUTEONSETPEAKDURATION
Inhaln1 minunknown1–3 hr
SUBQ5–10 min20 min<1–4 hr
IM6–12 minunknown<1–4 hr
IVrapid20 min20–30 min



Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CV: angina, arrhythmias, hypertension, tachycardia

Derm: skin and soft tissue infections (including necrotizing fasciitis and myonecrosis)

Endo: hyperglycemia

GI: nausea, vomiting

GU: renal impairment

Neuro: nervousness, restlessness, tremor, headache, insomnia

Resp: PARADOXICAL BRONCHOSPASM (WITH EXCESSIVE USE OF INHALERS), pulmonary edema

Interactions

Drug-drug:

Drug-Natural Products:

Route/Dosage

Availability

(Generic available)

Assessment

Lab Test Considerations:

Toxicity and Overdose:

Implementation

IV Administration:

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Adrenaclick, Adrenalin, AsthmaNefrin, Auvi-Q, EpiPen, Primatene Mist, Symjepi, Twin-Ject

Canadian Brand Names

Allerject, Anapen, Anapen Junior, S-2 (racepinephrine)

Code

NDC Code